Albireo Stock Buy Hold or Sell Recommendation


USD 23.78  0.84  3.66%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Albireo Pharma is 'Strong Hold'. Macroaxis provides Albireo Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALBO positions. The advice algorithm takes into account all of Albireo Pharma's available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Albireo Pharma's buy-and-hold perspective. Please continue to Albireo Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Albireo and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Albireo Pharma.

Execute Albireo Pharma Buy or Sell Advice

The Albireo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Albireo Pharma. Macroaxis does not own or have any residual interests in Albireo Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Albireo Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Albireo PharmaBuy Albireo Pharma
Strong Hold



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

For the selected time horizon Albireo Pharma has a Risk Adjusted Performance of 0.1774, Jensen Alpha of 0.4029, Total Risk Alpha of 0.1713, Sortino Ratio of 0.1061 and Treynor Ratio of 0.4798
Our investment recommendation module complements current analysts and expert consensus on Albireo Pharma. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Albireo Pharma is not overpriced, please confirm all Albireo Pharma fundamentals, including its revenue, current ratio, and the relationship between the number of shares shorted and cash and equivalents . Given that Albireo Pharma has a price to earning of (4.16) X, we suggest you to validate Albireo Pharma market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Albireo Pharma Trading Alerts and Improvement Suggestions

Albireo Pharma appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 40.58 M. Net Loss for the year was (34.03 M) with profit before overhead, payroll, taxes, and interest of 39.22 M.
Albireo Pharma currently holds about 180.97 M in cash with (107.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.23.
Albireo Pharma has a frail financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Sale by Weisman Scott of 3851 shares of Albireo Pharma

Albireo Pharma Returns Distribution Density

The distribution of Albireo Pharma's historical returns is an attempt to chart the uncertainty of Albireo Pharma's future price movements. The chart of the probability distribution of Albireo Pharma stock daily returns describes the distribution of returns around its average expected value. We use Albireo Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Albireo Pharma returns is essential to provide solid investment advice for Albireo Pharma.
Mean Return0.54Value At Risk-5.06
Potential Upside10.04Standard Deviation4.75
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Albireo Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Albireo Pharma Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure4.31 M(47 K)(540 K)(78 K)(465 K)(477.24 K)
Depreciation Amortization and Accretion35 K45 K127 K192 K274 K282.35 K
Net Cash Flow or Change in Cash and Cash Equivalents23.3 M110.65 M(32.04 M)119.43 M(3.17 M)(3.25 M)
Issuance Purchase of Equity Shares48.51 M94.66 M23.5 M196.04 M2.76 M2.83 M
Net Cash Flow from Financing45.84 M139.18 M23.5 M220.28 M2.76 M2.83 M
Net Cash Flow from Investing4.31 M(47 K)(540 K)(78 K)102.92 M111.05 M
Net Cash Flow from Operations(27.57 M)(26.8 M)(52.92 M)(101.03 M)(107.56 M)(110.39 M)
Effect of Exchange Rate Changes on Cash718 K(1.68 M)(2.09 M)260 K(1.29 M)(1.32 M)
Share Based Compensation3.7 M5.55 M7.58 M14.62 M15.93 M17.19 M

Albireo Pharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Albireo Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Albireo Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Albireo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite1.10
Overall volatility
Information ratio 0.09

Albireo Pharma Volatility Alert

Albireo Pharma shows above-average downside volatility for the selected time horizon. We advise investors to inspect Albireo Pharma further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Albireo Pharma future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Albireo Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Albireo Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Albireo Pharma Fundamentals Vs Peers

Comparing Albireo Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Albireo Pharma's direct or indirect competition across all of the common fundamentals between Albireo Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Albireo Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Albireo Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Albireo Pharma by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Albireo Pharma to competition
FundamentalsAlbireo PharmaPeer Average
Return On Equity(0.93) %(0.31) %
Return On Asset(0.25) %(0.14) %
Profit Margin(2.29) %(1.27) %
Operating Margin(2.15) %(5.51) %
Current Valuation284.82 M16.62 B
Shares Outstanding20.7 M571.82 M
Shares Owned by Insiders0.53 %10.09 %
Shares Owned by Institutions97.24 %39.21 %
Number of Shares Shorted1.08 M4.71 M
Price to Earning(4.16) X28.72 X
Price to Book4.55 X9.51 X
Price to Sales8.04 X11.42 X
Revenue40.58 M9.43 B
Gross Profit39.22 M27.38 B
EBITDA(19.82 M)3.9 B
Net Income(34.03 M)570.98 M
Cash and Equivalents180.97 M2.7 B
Cash per Share9.23 X5.01 X
Total Debt10 M5.32 B
Debt to Equity0.18 %48.70 %
Current Ratio4.49 X2.16 X
Book Value Per Share4.84 X1.93 K
Cash Flow from Operations(107.56 M)971.22 M
Short Ratio5.09 X4.00 X
Earnings Per Share(1.70) X3.12 X
Target Price58.67
Number of Employees13018.84 K
Market Capitalization461.64 M19.03 B
Total Asset302.05 M29.47 B
Retained Earnings(171.75 M)9.33 B
Working Capital26.76 M1.48 B
Current Asset28.84 M9.34 B
   Sale by Weisman Scott of 3851 shares of Albireo Pharma [view details]

Albireo Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Albireo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Albireo Pharma Buy or Sell Advice

When is the right time to buy or sell Albireo Pharma? Buying financial instruments such as Albireo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Receivables2.94 M3.18 M
Inventories174.6 K173.58 K

Use Investing Ideas to Build Portfolios

In addition to having Albireo Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Transportation Thematic Idea Now

Transportation Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Transportation theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Transportation Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Albireo Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
461.6 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.